Repeated spontaneous abortion. Cooperative effects of ADA and ACP1 genetic polymorphisms

American Journal of Reproductive Immunology

Volumn 58, Issue 1, 2007, Pages 1-10

  Nicotra, M ^a   Bottini, N ^b   La Torre, M ^c   Amante, A ^b   Bottini, E ^b   Gloria Bottini, Fulvia ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c S Massimo Hospital   (Italy)

Author keywords

ACP1; ADA; cLMWPTP; Repeated spontaneous abortion; Signal transduction

Indexed keywords

ADENOSINE DEAMINASE; AUTOANTIBODY; PROTEIN ACP1; PROTEIN TYROSINE PHOSPHATASE; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ANTIBODY TITER; ARTICLE; BLOOD GROUP INCOMPATIBILITY; CAUCASIAN; CHI SQUARE TEST; CONTINGENCY TABLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENETIC POLYMORPHISM; GENETIC RESISTANCE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; INCIDENCE; ITALY; LOGLINEAR MODEL; MAJOR CLINICAL STUDY; NEWBORN; PHENOTYPE; PRIORITY JOURNAL; RECURRENT ABORTION; SPONTANEOUS ABORTION;

ABORTION, SPONTANEOUS; ADENOSINE DEAMINASE; ADULT; AUTOANTIBODIES; FEMALE; FERTILITY; HUMANS; INFANT, NEWBORN; POLYMORPHISM, GENETIC; PREGNANCY; PROTEIN-TYROSINE-PHOSPHATASE; PROTO-ONCOGENE PROTEINS; ROME;

EID: 34250632793     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2007.00483.x     Document Type: Article

References (39)

1. Nicotra M, Bottini N, Grasso M, Gimelfarb A, Lucarini N, Cosmi E, Bottini E: Adenosine deaminase and humAn reproduction: a comparative study of fertile women and women with recurrent spontaneous abortion. Am J Reprod Immunol 1998; 39: 266-270.
2. Gloria-Bottini F, Nicotra M, Lucarini N, Borgiani P, La Torre M, Amante A, Gimelfarb A, Bottini E: Phosphotyrosine-protein-phosphatases and human reproduction: An association between low molecular weight acid phosphatase (ACP1) and spontaneous abortion. Dis Markers 1996; 12: 261-269.
3. Amante A, GloriA-Bottini F, Bottini E: Intrauterine growth: association with acid phosphatase genetic polymorphism. J Perinat Med 1990; 18: 275-282.
4. Park EK, Warner N, Mood K, Pawson T, Daar IO: Low-molecular-weight protein tyrosine phosphatase is a positive component of the fibroblast growth factor receptor signalling pathway. Mol Cell Biol 2002; 22: 3404-3414.
5. Knudsen TB, Gray MK, Church JK, Blackburn MR, Airhart MJ, Kellems RE, Skalko RG: Early postimplantation embryolethality in mice following in utero inhibition of adenosine deaminase with 2′-deoxycoformycin. Teratology 1989; 40: 615-626.
6. Blackburn MR, Datta SK, Kellems RE: Adenosine deaminase-deficient mice generated using a two-stage genetic engineering strategy exhibit a combined immunodeficiency. J Biol Chem 1998; 273: 5093-5100.
7. Yoneyama Y, Sawa R, Suzuki S, Ishino H, Miura A, Kuwabara Y, Kuwajima T, Ito N, Kiyokawa Y, Otsubo Y, Araki T: Regulation of plasma adenosine levels in normal pregnancy. Gynecol Obstet Invest 2002; 53: 71-74.
8. Spencer N, Hopkinson DA, Harris H: Quantitative differences and gene dosage in the human red cell phosphatase polymorphism. Nature 1964; 201: 299-300.
9. Modiano G, Filippi G, Brunelli P, Frattaroli W, Siniscalco M: Studies on red cell acid phosphatases in Sardinia and Rome: Absence of correlation with past malarial morbidity. Acta Genet Basel 1967; 17: 17-28.
10. Bottini E, Gloria-Bottini F, Borgiani P: ACP1 and human adaptability. 1. Association with common disease: A case-control study. Hum Genet 1995; 96: 629-637.
11. Bottini N, Stefanini L, Williams S, Alonso A, Jascur T, Abraham RT, Couture C, Mustelin T: Activation of ZAP-70 through specific dephosphorylation at the inhibitory Tyr-292 by the low molecular weight phosphotyrosine phosphatase (LMPTP). J Biol Chem 2002; 277: 24220-24224.
12. Spencer N, Hopkinson D, Harris H: Adenosine deaminase polymorphism in man. Ann Hum Genet 1968; 32: 9-14.
13. Battistuzzi C, Scozzari R, Santolamazza P, Terrenato L, Modiano G: Comparative activity of red cell adenosine deaminase allelic forms. Nature 1974; 251: 712.
14. Kameoka J, Tanaka T, Nojima Y, Schlossman SF, Morimoto C: Direct association of adenosine deaminase with T cell activation antigen CD26. Science 1993; 261: 466-469.
15. Richardson PJ: Blocking adenosine with antisense. Nature 1997; 385: 684-685.
16. Xu B, Berkich DA, Crist GH, La Noue K: A1 adenosine receptor antagonism improves glucose tolerance in Zucker rats. Am Phys Soc 1998; 274: 271-279.
17. Dong RP, Kameoka J, Hegen M, Tanaka T, Xu Y, Schlossman SF, Morimoto C: Characterisation of adenosine deaminase binding to human CD26 on T cells and its biologic role in immune response. J Immunol 1996; 156: 1349-1355.
18. Lucarini N, Borgiani P, Ballarini P, Bottini E: Erythrocyte acid phosphatase (ACP1) activity: In vitro modulation by adenosine and inosine and effects of adenosine deaminase (ADA) polymorphism. Hum Genet 1989; 81: 185-187.
19. Danielsen AG, Liu F, Hosomi K, Shi K, Roth RA: Activation of protein kinase C-alpha inhibits signalling by members of the insulin receptor family. J Biol Chem 1995; 270: 21600-21605.
20. Dent P, Reardon DB, Wood SL: Inactivation of raf-1 by a protein tyrosine phosphatase stimulated by GTP and reconstituted by GA1/0 subunits. J Biol Chem 1996; 271: 3119-3123.
21. Reardon DB, Wood SL, Brautgan DL, Bell GI, Dent P, Stargill TW: Activation of a protein tyrosine phosphatase and inactivation of Raf-1 by somatostatin. Biochem J 1996; 314: 401-404.
22. Prlusch R, Buchholz T, Lohse P, Rubsamen H, Rogenhofer N, Hasbargen U, Hiller E, Thaler CJ: Thrombophilic gene mutations and recurrent spontaneous abortion: Protrombin mutation increases the risk in the first trimester. Am J Reprod Immunol 2001; 46: 124-131.
23. Hopkinson DA, Spencer N, HarriA H: Red cell acid phosphatase variants: a new human polymorphism. Nature 1963; 199: 969-971.
24. Briolay J, Gioud M, Monier JC, Rodde JL, Cohen J, Roux B, Kaliss B: Antinuclear antibodies detected by indirect immunofluorescence on Hep2 cells and by immunoblotting in patients with systemic sclerosis. Autoimmunity 1998; 2: 165-176.
25. Goulvestre C: Antinuclear antibodies. Presse Med 2006; 35: 287-295.
26. Nie NH, Hull CH, Jenkins JG, Steinbrenner K, Bent DH: SPSS/PC+ Version 5.0. Chicago, SPSS Inc, 1992.
27. Sokal RR, Rohlf JF: Biometry. New York, WH Freeman, 1981.
28. Scozzari R, Santolamazza C, Carapella E: Studies on the red cell adenosine deaminase polymorphism in Rome. Humagenetik 1970; 8: 364-365.
29. Bottini N, Meloni GF, Finocchi A, Ruggiu G, Amante A, Meloni T, Bottini E: Maternal-fetal interaction in the ABOAsystem: a comparative analysis of healthy mothers and couples with recurrent spontaneous abortion suggests a protective effect of B incompatibilità. Hum Biol 2001; 73: 167-174.
30. Gimelfarb A, Bottini E: Age differences between distributions of genotypes among pregnant women: Evidence of fertility selection. Gen Res Camb 1989; 53: 207-214.
31. Gloria-Bottini F, Gerlini G, Lucarini N, Borgiani P, Amante A, La Torre M, Antonacci E, Bottini E: Phosphotyrosine protein phosphatases and diabetic pregnancy. An association between low molecular weight acid phosphatase (ACP1) and degree of glycemic control. Experientia 1996; 52: 340-343.
32. Lucarini N, Antonacci E, Bottini N, Borgiani P, Faggioni G, Gloria-Bottini F: Phosphotyrosine protein phosphatase and diabetic disorders. Further studies on the relationship between low molecular weight acid phosphatase genotype and degree of glycemic control. Dis Markers 1998; 14: 121-125.
33. Lucarini N, Antonacci E, Bottini N, Gloria-Bottini F: Low-molecular-weight acid phosphatase (ACP1), obesity, and blood lipid levels in subjects with non-insulin-dependent diabetes mellitus. Hum Biol 1997; 69: 509-515.
34. Boivin P, Galand C: The human red cell acid phosphatase is a phosphotyrosine protein phosphatase which dephosphorylates the membrane protein band 3. Biochem Biophys Res Commun 1986; 134: 557-564.
35. Fucks KR, Shekels LL, Bernlohr DA: Analysis of the ACP1 gene product-classification as an FMN phosphatase. Biochem Biophys Res Commun 1992; 189: 1598-1605.
36. Low PS, Allen DP, Zioncheck TF, Chiari P, Willardson PN, Geahlen RL, Harrison ML: Tyrosine phosphorylation of band 3 inhibits peripheral protein binding. J Biol Chem 1987; 262: 4592-4595.
37. Xu B, Berkich DA, Crist Gh, La Nouse KF: A 1 adenosine receptor antagonism improves glucose tolerance in Zucker rats. Am J Physiol 1998; 274: E271-279.
38. Yasuda N, Inoue T, Horizoe T, Nagata K, Minami H, Kwata T, Hoshino Y, Harada H, Yoshikawa S, Asano O, Nagaoka J, Murakami M, Abe S, Kobayashi S, Tanaka I: Functional characterization of the adenosine receptor contributing to glycogenolysis and gluconeogenesis in rat hepatocytes. Eur J Pharmacol 2003; 459: 159-166.
39. Bottini N, Gloria-Bottini F, Borgiani P, Antonacci E, Lucarelli P, Bottini E: Type 2 diabetes and the genetics of signAl transduction: a study of interaction between adenosine deaminase and acid phosphatase locus 1 polymorphisms. Metabolism 2004; 8: 995-1001.